BMRN Competitors & Alternatives
Compare Biomarin Pharmaceutical Inc with similar stocks in the same industry
Biotechnology
BMRN
Main Stock$65.84
Tradestie Score
39
Market Cap
$10.53B
P/E Ratio
180.3
Revenue Growth
0.2%
Analyst Upside
+38.3%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$62.03
|
$15.70B | 33.0 | 40 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.30
|
$15.22B | - | 46 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$252.05
|
$12.36B | 19.4 | 50 | Compare |
|
EXEL
Exelixis Inc
|
$55.97
|
$11.09B | 17.0 | 51 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.41
|
$10.76B | - | 45 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$156.68
|
$10.74B | - | 36 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$63.33
|
$10.49B | - | 37 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$80.54
|
$10.22B | - | 53 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$516.05
|
$10.01B | - | 52 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.33
|
$9.33B | 62.3 | 51 | Compare |
More BMRN Analysis
Data updated: Aug 25, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry